Can Peng
Impact in
- Pharmacology top 2%
-
- Traditional Chinese Medicine Analysis
Papers in
-
- Metabolomics and Mass Spectrometry Studies 7
- Natural product bioactivities and synthesis 6
- Pharmacology 17
- Pharmacological Effects of Natural Compounds 9
- Fungal Biology and Applications 6
- Plant-based Medicinal Research 5
- Co-authors
- Weidong Chen (16 shared papers)Lei Wang (5 shared papers)Daiyin Peng (17 shared papers)Qianqian Huang (2 shared papers)Hong Chen (1 shared paper)Huihui Wang (1 shared paper)Yifan Wu (1 shared paper)Zhen Qiu (1 shared paper)
- Journals
- Frontiers in Pharmacology (6 papers)Journal of Pharmaceutical and Biomedical Analysis (3 papers)International Journal of Pharmaceutics (3 papers)Molecular Cytogenetics (2 papers)Nutrients (2 papers)
- Partner nations
- ChinaCanadaUnited Kingdom
In The Last Decade
Can Peng
91 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Pharmacology 166
- Complementary and alternative medicine 154
- Cancer Research 242
- Molecular Biology 829
- Biomaterials 152
Countries citing papers authored by Can Peng
This map shows the geographic impact of Can Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Peng more than expected).
Fields of papers citing papers by Can Peng
This network shows the impact of papers produced by Can Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Peng. The network helps show where Can Peng may publish in the future.
Co-authors
The 25 scholars most cited alongside Can Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Exosomes from M1-Polarized Macrophages Enhance Paclitaxel Antitumor Activity by Activating Macrophages-Mediated Inflammation Hit paper breakdown → | 2019 | 382 |
| 2 | 2019 | 155 | |
| 3 | 2020 | 63 | |
| 4 | 2018 | 55 | |
| 5 | 2022 | 54 | |
| 6 | 2020 | 45 | |
| 7 | 2023 | 40 | |
| 8 | 2012 | 40 | |
| 9 | 2013 | 37 | |
| 10 | 2020 | 34 | |
| 11 | 2021 | 34 | |
| 12 | 2020 | 33 | |
| 13 | 2023 | 30 | |
| 14 | 2020 | 30 | |
| 15 | 2019 | 28 | |
| 16 | 2020 | 28 | |
| 17 | 2022 | 26 | |
| 18 | 2022 | 26 | |
| 19 | 2022 | 26 | |
| 20 | 2019 | 23 |
About Can Peng
Can Peng is a scholar working on Molecular Biology, Pharmacology, Complementary and alternative medicine, Pharmacology and Genetics, having authored 101 papers that have together received 1.7k indexed citations. Recurring topics across this work include Traditional Chinese Medicine Analysis (10 papers), Pharmacological Effects of Natural Compounds (9 papers), Metabolomics and Mass Spectrometry Studies (7 papers), Prenatal Screening and Diagnostics (6 papers), Natural product bioactivities and synthesis (6 papers), Fungal Biology and Applications (6 papers), Plant-based Medicinal Research (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (5 papers). The work is most often cited by research in Pharmacology (166 citations), Complementary and alternative medicine (154 citations), Cancer Research (242 citations), Molecular Biology (829 citations) and Biomaterials (152 citations). Can Peng has collaborated with scholars based in China, Canada and United Kingdom. Frequent co-authors include Weidong Chen, Lei Wang, Daiyin Peng, Qianqian Huang, Hong Chen, Huihui Wang, Yifan Wu, Zhen Qiu, Liang Yao and Xianchun Duan. Their work appears in journals such as Frontiers in Pharmacology, Journal of Pharmaceutical and Biomedical Analysis, International Journal of Pharmaceutics, Molecular Cytogenetics and Nutrients.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.